New Enterprise Associates

New Enterprise Associates (NEA) is a prominent venture capital firm established in 1977, headquartered in Menlo Park, California, with additional offices in the U.S., India, and China. NEA specializes in investing in technology and healthcare sectors, with a focus on enterprise, consumer, fintech, life sciences, and digital health companies. The firm engages with entrepreneurs at various stages of business development, providing support from initial funding to public offerings. NEA invests globally, with a significant presence in Asia, including China and India, as well as the United States. The firm typically invests between $0.05 million and $20 million per deal.

Michael Albert

Associate

Kate Barrett

Partner, Communications

Ron Bernal

Venture Partner

Ann Bordetsky

Partner

Zak Burns

Associate

James Buxton MD

Principal

Carmen Chang

Partner and Head of Asia

Philip Chopin

Managing Director, NEA UK

Brandon Christie

VC Principal

Pamela Clark

General Partner

Vanessa Deng

Associate

Chris Doppman

Managing Director, LP Relations

Jonathan Golden

Partner

Scott Gottlieb MD

Partner

Jay Graf

Venture Partner

Aaron Jacobson

Partner

Arjun Jain

Senior Associate

James Kaplan

Associate

Nick Kline

Partner, LP Relations

Danielle Lay

Partner

Tiffany Le

Principal

Michael Li

Principal

Tiffany Luck

Partner

Ed Mathers

Partner and Board Member

Matthew McAviney

Partner

Michael O'Dell

Venture Partner

Kemi Odusan

Senior Associate

Jess Ou

Principal

Greg Papadopoulos

Venture Partner

Michele Park

Partner

Eileen Qian

Associate

Tim Schaller

CFO

Alex Sharata

Partner

George Stamas

Venture Partner

Brad Thawley

Partner, Limited Partner Relations

Blake Wu

Partner

Lulu Xu

Principal

Edison Zhang

Associate

J.C. Lopez

Principal on NEA's Healthcare Team

Arno Penzias Ph.D

Venture Partner

Past deals in Early Venture Stage

Glacier

Series A in 2025
Glacier, founded in 2019 and headquartered in San Francisco, California, specializes in the development of advanced recycling robots. The company has created the first affordable, high-performing, and space-efficient AI-enabled robots designed to transform the operations of recycling facilities. By utilizing artificial intelligence-powered sensors and robotics, Glacier's technology automates the sorting of recyclable materials, allowing facilities to enhance operational efficiency, improve sorting accuracy, and increase overall profitability. Through its innovative approach, Glacier aims to revolutionize the recycling industry and promote more effective waste management practices.

Aetherflux

Series A in 2025
Aetherflux is an aerospace company focused on providing renewable energy solutions to households, businesses, and military operations worldwide. The company has developed an innovative design for space-based solar power, which entails a constellation of small satellites that harness sunlight, convert it into electricity, and wirelessly transmit the power to ground stations. This technology aims to deliver reliable energy distribution while minimizing environmental impact, positioning Aetherflux at the forefront of the renewable energy sector.

Cambium Carbon

Series A in 2025
Cambium Carbon is an early-stage social enterprise focused on addressing climate change through innovative reforestation and urban wood reuse initiatives. The company collaborates with cities and various public and private partners to salvage fallen city trees that would otherwise end up in landfills. By transforming this wood waste into valuable resources, Cambium Carbon establishes reforestation hubs that create a circular economy for urban forests. These hubs not only generate revenue to support tree planting and maintenance projects but also foster sustainable job creation and contribute to the development of resilient urban environments. Through its efforts, Cambium Carbon aims to implement systems-level natural climate solutions that benefit both the environment and local communities.

Moises

Series A in 2025
Moises is an audio technology company focused on enhancing music and audio processing through machine learning and data science. It provides a platform equipped with advanced artificial intelligence tools designed for musicians and producers. Key features of the platform include audio separation, pitch and beat detection, chord detection, a metronome, tempo changing, and mastering capabilities. These tools empower users to practice, study, teach, and play music, allowing for greater customization and editing of tracks. Moises aims to support creative processes by leveraging innovative technology tailored to the needs of the music community.

Ouro Medicines

Series A in 2025
Ouroboros Medicines is a biotechnology company dedicated to immunology, focusing on treating chronic immune-mediated illnesses. It specializes in developing immune reset treatments, using a therapeutic platform that employs T cell engager antibodies to target and deplete specific pathogenic cells. This approach aims to provide extended remissions for patients, without the need for ongoing immunosuppression. The company's strength lies in its integration of scientific knowledge and proven track record in progressing cell-depleting treatments through clinical trials, supported by a robust pipeline.

Orbis Medicines

Series A in 2025
Orbis Medicines is a biotechnology company focused on advancing drug discovery through its innovative macrocyclic chemistry and computational platform. The company specializes in high-throughput drug discovery, aiming to develop new therapeutics that can significantly improve patient outcomes. By leveraging its unique chemistry and advanced computational techniques, Orbis Medicines seeks to address challenging targets in areas with high unmet medical needs, thereby accelerating the process of bringing effective treatments to market.

Backflip AI

Series A in 2024
Backflip AI operates a platform that combines human creativity with 3D generative AI, enabling engineers and designers to work efficiently and produce highly realistic models. These models can be used in various applications, such as 3D printing, video game assets, renders, and digital media, as well as in the design of physical structures like buildings and automobiles. The company's technology aims to accelerate design processes and provide businesses with a competitive edge.

Avenzo

Series A in 2024
Avenzo Therapeutics is a clinical-stage biotechnology company dedicated to developing innovative therapies for oncology, specifically targeting underserved and rare cancers. The company operates a specialized platform that focuses on creating novel treatments aimed at genomically defined cancer types. By prioritizing targeted therapies, Avenzo Therapeutics seeks to advance cancer treatment options for patients who may not have access to effective solutions, thus addressing significant gaps in the current therapeutic landscape.

Genmo

Series A in 2024
Genmo is a technology company that develops an artificial intelligence platform for creative content generation. Its platform enables users to create high-quality videos, images, and 3D models using intuitive text and image prompts, leveraging advanced natural language processing technology. This allows video creators to generate custom visual media and produce cinematic video content with the assistance of AI.

Firestorm

Series A in 2024
Firestorm is a company focused on developing modular open-source architecture tailored to meet the requirements of the Department of Defense, emphasizing the creation of low-cost and affordable solutions. It specializes in the manufacture of loitering munitions and mission-adaptable systems, designed to enhance aerial weaponry. Firestorm's systems are characterized by their modularity and precision payload delivery, equipping paratroopers with advanced aircraft suitable for modern, hyper-enabled battlefields.

DeltaStream

Series A in 2024
DeltaStream is a stream processing platform designed to assist businesses in processing and analyzing real-time streaming data. By leveraging the capabilities of Apache Flink, the platform offers serverless stream processing and a range of features such as data governance, real-time analytics, multi-platform capabilities, and monitoring. DeltaStream facilitates the creation of materialized views and supports third-party sharing, allowing organizations to efficiently manage their streaming analytics and database needs. With its emphasis on scalability and ease of use, the platform enables businesses to harness the full potential of their streaming data without the burden of infrastructure management.

Sakana AI

Series A in 2024
Sakana AI is a research-focused company dedicated to developing innovative foundation models inspired by nature. It specializes in creating an AI model capable of generating text, images, video, code, and multimedia, facilitating collaborative research and development in generative AI. The company's AI development process emphasizes evolution and collective intelligence.

Amber Therapeutics

Series A in 2024
Amber Therapeutics is a biotechnology company that specializes in developing advanced bioelectrical therapies aimed at treating functional disorders of the peripheral nervous system. The company creates a bioelectronic platform that delivers closed-loop bioelectrical treatments, which can sense and adapt to the patient's needs while also providing stimulation. By focusing on conditions such as mixed urinary incontinence, Amber Therapeutics seeks to enhance clinical efficacy and patient outcomes through innovative approaches that emphasize the peripheral nervous system rather than the central nervous system. Its technology has the potential to significantly improve treatment methods and overall patient care in targeted disease areas.

Twelve Labs

Series A in 2024
Twelve Labs is a developer of a multimodal artificial intelligence platform that focuses on enhancing video understanding capabilities for businesses and developers. The platform enables users to analyze and interpret video content through various modalities, including visual and auditory data. It offers APIs for functions such as search, generation, and classification, allowing clients to create embeddings from videos to support a range of applications. Twelve Labs' technology is applicable across various industries, including technology, media, entertainment, and security, facilitating the development of intelligent video applications that can be deployed on any cloud and customized with specific data to meet user needs.

Xaira Therapeutics

Venture Round in 2024
Xaira Therapeutics is a biotechnology company based in the San Francisco Bay Area that focuses on leveraging artificial intelligence to enhance drug discovery and development. The company integrates machine learning research, extensive biological and clinical data generation, and therapeutic product development to innovate how diseases are treated. By employing advanced AI methodologies, Xaira aims to transform the traditional drug development process, enabling the creation of more effective therapies. Through its multidisciplinary approach, the company seeks to advance understanding of biology and improve the overall efficiency of developing new treatments.

AI Squared

Series A in 2024
AI Squared helps large organizations bring AI to where work happens. We do this by leveraging our SaaS or on-prem platform which combines data sources with advanced AL/ML functionality and embeds intelligent insights into critical business applications. Trusted by the largest financial institutions, the most complicated supply chain logistics companies, and the US Department of Defense, we enable seamless collaboration between data science teams and business users, driving faster, more informed decision-making.

Avenzo

Series A in 2024
Avenzo Therapeutics is a clinical-stage biotechnology company dedicated to developing innovative therapies for oncology, specifically targeting underserved and rare cancers. The company operates a specialized platform that focuses on creating novel treatments aimed at genomically defined cancer types. By prioritizing targeted therapies, Avenzo Therapeutics seeks to advance cancer treatment options for patients who may not have access to effective solutions, thus addressing significant gaps in the current therapeutic landscape.

Foundry

Series A in 2024
Foundry is a public cloud supported by an orchestration platform designed to simplify the utilization of AI computing resources. Foundry addresses fundamental economic and technical obstacles encountered in AI and deep learning. Current challenges faced by businesses, such as the notable GPU scarcity and inefficient use of computing capabilities, hinder their effective utilization of resources. Foundry employs pioneering approaches to overcome these hurdles, offering scalable GPU instances with unparalleled price-performance ratios.

Together AI

Series A in 2024
Together is a technology services platform that offers a decentralized cloud specifically for artificial intelligence development. The company focuses on constructing open-source generative AI models and infrastructure, providing tools and resources that enable developers and researchers to train, refine, and deploy these models efficiently. Together's platform emphasizes accessibility and user-friendliness, allowing organizations of various sizes to leverage and enhance AI capabilities. By contributing innovative open-source research, models, and datasets, Together plays a significant role in advancing the field of AI and fostering collaborative development efforts.

Mojo Vision

Series A in 2023
Mojo Vision Inc. is a technology company based in Saratoga, California, founded in 2015. The company specializes in the development of augmented reality solutions, focusing on high-performance micro-LED display technology. Mojo Vision has created the world's smallest and densest dynamic display for smart contact lenses, which are designed to provide users with timely information seamlessly and hands-free, without the distractions associated with traditional mobile devices. The company is also engaged in a joint development agreement with Menicon Co., Ltd. to explore smart contact lens products, further enhancing its innovative offerings. By combining advanced display and semiconductor expertise with proprietary quantum-dot technology, Mojo Vision aims to revolutionize the display industry, addressing diverse applications across consumer, enterprise, and government sectors.

Rocket.Chat

Series A in 2023
Rocket.Chat Holdings, Ltd., established in 2015, specializes in developing and operating an open-source web chat platform. The company offers a comprehensive suite of features, including video conferencing, helpdesk chat, file sharing, and screen sharing, along with API and native mobile applications. Rocket.Chat also provides white labeling, integrations, and hosting services. With over 500,000 servers installed and 12 million users worldwide, the platform facilitates internal and external communication within a secure environment. Users can run Rocket.Chat on-premises or on the cloud, tailoring the platform with features like individual and group communication, video conferencing, and integration with various external communications platforms. The company's long-term vision is to replace email with a real-time, federated communications platform and foster a marketplace for app-building and services.

Nexo Therapeutics

Series A in 2023
Nexo Therapeutics is a small molecule oncology company focused on discovering and developing innovative drugs for cancer patients who have limited therapeutic options. The company utilizes a unique platform that integrates covalent ligand discovery and chemical biology, allowing it to advance small-molecule therapies aimed at challenging and previously intractable cancer targets. By unlocking a pipeline of novel oncology treatments, Nexo Therapeutics seeks to provide medical professionals with new and effective options to improve patient outcomes in the fight against cancer.

Tagworks Pharmaceuticals

Series A in 2023
Tagworks Pharmaceuticals is a privately held biotech company based in the Netherlands, established in 2011 as a spin-out from Philips Healthcare. The company focuses on developing innovative in vivo chemistry to enhance the effectiveness of cancer therapies and to facilitate novel companion diagnostics. Operating from the Radboud University Medical Center in Nijmegen, Tagworks specializes in antibody-based imaging and therapy technologies. Its proprietary approach allows for the selective chemical manipulation of tagged antibodies in vivo, which improves the efficacy of established methods like radioimmuno-imaging and antibody-drug conjugates. This technology enables medical professionals to conduct imaging with significantly reduced radiation exposure for patients.

Djust

Series A in 2023
Djust is a company that specializes in providing a cloud-based B2B platform aimed at accelerating the launch of e-commerce and e-procurement solutions for businesses. The platform integrates digital showrooms, an e-commerce marketplace, and customer relationship management (CRM) systems into a single product, streamlining the process for clients to establish and enhance their online business presence. By offering this comprehensive solution, Djust simplifies the complexities of setting up digital commerce for businesses, making it easier for them to engage in online transactions and expand their operations.

Granica

Series A in 2023
Granica is a company that specializes in enhancing the efficiency and safety of artificial intelligence applications through its AI Data Readiness Platform. This platform assists data engineers and leaders in creating AI-ready data, which is crucial for optimizing machine learning models and analytics. By improving the efficiency of tabular and natural language processing training data, Granica significantly reduces storage costs and enhances query performance. The company focuses on mitigating risks associated with sensitive data leakage and harmful content, thereby ensuring privacy and safety in AI inputs and outputs. Granica curates and refines training datasets to select impactful samples, ultimately boosting the performance and reliability of AI models. Targeting enterprises in data-intensive sectors such as financial services, retail, geo-spatial intelligence, and autonomous vehicles, Granica enables clients to leverage AI more effectively, enhancing trust and improving business outcomes.

Union.ai

Series A in 2023
Union.ai is a Kubernetes-native workflow orchestration platform for data and machine learning at scale. Union.ai provides software users with the tools they need to move their ideas from concept to high-quality production. Union's aim is to organize the numerous processes required to train and grow the most sophisticated and dynamic machine learning and data products.

Limitless

Series A in 2023
Rewind is a personalized AI powered by everything you’ve seen, said, or heard.

Kira

Venture Round in 2023
Kira Learning is an AI-driven education technology company that creates innovative tools and solutions to support educators and students. Its primary mission is to empower schools, districts, and teachers by integrating cutting-edge artificial intelligence into educational practices, making teaching more effective and learning more engaging.

Kindred

Series A in 2023
Kindred is a unique travel company focused on creating a trusted network for exchanging homes. Unlike traditional vacation rental platforms, Kindred operates as a members-only network where participants must host their own homes to remain guests. This model fosters a higher level of trust among members, who are peers looking to travel more frequently rather than professional hosts renting investment properties. By eliminating cash exchanges between guests and hosts, Kindred enables its members to enjoy a travel-rich lifestyle at a significantly lower cost compared to hotels or traditional vacation rentals.

SimpleRose

Venture Round in 2023
SimpleRose Inc. is a technology company based in Saint Louis, Missouri, that specializes in developing a prescriptive analytics platform aimed at enhancing decision-making in complex environments. Founded in 2018, the company offers solutions that optimize and accelerate processes such as scheduling, production planning, and portfolio optimization. By leveraging advanced algorithmic innovations, SimpleRose’s platform provides high levels of numerical accuracy, speed, and the capability for continuous analysis, enabling organizations to effectively address operational challenges and make informed decisions.

Perplexity

Series A in 2023
Perplexity is an artificial intelligence-based search engine platform that combines large language models with traditional search engines. It leverages natural language processing and generative AI technologies to deliver conversational responses to user queries, aiming to enhance the search experience beyond standard results. The platform is designed to facilitate the development of safe and beneficial artificial general intelligence, offering an open-source environment accessible to the public. This allows clients to acquire skills and knowledge in software development, positioning Perplexity as a bridge between conventional search capabilities and advanced AI-driven assistance.

OP3N

Series A in 2023
Founded in 2021 as a subsidiary of EST Media Holdings, OP3N is a global Web3 superapp designed to streamline communication, connection, and commerce through on-chain interactions within a unified interface. The company's mission is to foster a decentralized and democratized creator economy, providing the necessary tools for minting, sharing, and engaging with digital goods and tokens. OP3N's leadership team includes Jaeson Ma, a media executive and entrepreneur with a successful track record in launching companies, and Eric Tu, an award-winning development executive with experience collaborating with major brands and artists. The company is based in Los Angeles and has a diverse portfolio of projects that includes partnerships with fashion brand AMBUSH, an intergalactic children's book by Grimes, a musical film with Simon Fuller, and a music video by Ava Max directed by Joseph Kahn. OP3N specializes in empowering artists to connect directly with their fans through token-gated access, leveraging AI to enhance user experience in a community-centric environment.

Flox

Series A in 2023
Flox develops a web application that enhances developer productivity throughout the software development lifecycle. The company offers SaaS products that leverage Nix, allowing enterprises to install packages, manage development and production environments, and ensure consistent software deployment across embedded devices. By enabling developers to treat environments and packages as code, Flox streamlines the process of building and managing software, promoting efficiency and reliability in development practices.

Launchpad Therapeutics

Series A in 2022
Launchpad Therapeutics is a precision oncology company focused on developing innovative antibody-based treatments for cancer. The company specializes in creating mutant-selective antibodies designed to target specific mutations found in cancer cells. By leveraging artificial intelligence-driven programs, Launchpad Therapeutics aims to deliver novel monoclonal antibodies that offer new avenues for cancer treatment. These efforts are directed towards providing medical professionals with alternative and effective therapeutic options for patients.

Fizz

Series A in 2022
Fizz is an authorized platform designed to enhance community social structures, particularly within institutions. It develops online social media software that facilitates communication and the sharing of ideas, events, and experiences among users. The platform allows individuals to post secret confessions and ask questions within a closed community, promoting social interaction while maintaining anonymity. By leveraging these features, Fizz aims to foster a more connected and engaged community environment.

Partiful

Series A in 2022
Partiful is an online platform designed to facilitate the planning and organization of social events. It enables users to create and manage various types of gatherings, ranging from intimate dinners to larger parties, thereby fostering real-world connections among attendees. The platform simplifies the invitation process by allowing users to invite guests, including friends-of-friends, even when contact details are unavailable. By focusing on enhancing social interactions, Partiful aims to help individuals cultivate meaningful friendships and create memorable experiences through its user-friendly event planning tools.

Bliq

Series A in 2022
Bliq GmbH, established in 2019 and headquartered in Berlin, Germany, specializes in developing application software for gig workers in the transport industry. Its flagship product, Bliq Ride, enables registered drivers to automate their daily tasks by accepting or rejecting orders from multiple platforms simultaneously. The company's mission is to streamline work organization for rideshare and delivery drivers using traffic data, technology, and collective intelligence. As of now, Bliq employs 25 people.

PixieBrix

Series A in 2022
PixieBrix is a developer of a low-code browser extension that enhances web tools by enabling users to customize and automate their online experiences. The platform empowers teams, from entrepreneurs to large organizations, by allowing them to rapidly create and share modifications and integrations tailored to their specific needs. PixieBrix leverages advanced AI and automation technologies to optimize workflows and boost productivity. Its fully customizable extension integrates seamlessly into any website, facilitating quick implementation and delivering immediate benefits to users by enhancing functionality and streamlining processes.

QuoteWell

Series A in 2022
QuoteWell is a digital-first platform founded in 2021 and based in Austin, Texas, designed to meet the needs of the modern insurance sector. The company specializes in developing a data-driven platform that streamlines the insurance process. It offers an integrated submission system that allows agents and brokers to transmit insured applications to various commercial lines underwriters efficiently. By facilitating secure data transfers to multiple carriers, QuoteWell enhances access to a contemporary risk transfer infrastructure, empowering agents and brokers to manage their book of business effectively.

Arkestro

Series A in 2022
Arkestro is a technology company specializing in predictive procurement software designed to enhance savings and supply chain performance for businesses. Their platform pre-embeds preferred outcomes into any system or process, allowing companies to orchestrate activities across various systems using instant forecasts and real-time collaboration. By leveraging artificial intelligence, Arkestro's cloud-based automated negotiation software optimizes procurement savings and increases vendor participation, leading to significant cost reductions in managed services and raw materials solicitations.

Code Biotherapeutics

Series A in 2022
Code Biotherapeutics is a next-generation gene therapy company pioneering the development of targeted non-viral gene therapies to treat serious and life-threatening genetic diseases. Code Bio leverages its novel multivalent synthetic DNA delivery platform, 3DNA, which has been engineered to overcome many of the challenges inherent with viral-based gene therapies such as immunogenicity, size and delivery limitations, re-dosability, and manufacturing complexity. The company is advancing an internal pipeline focused on select rare disease programs as well as establishing partnerships to take forward programs in both rare and prevalent diseases.

Bliq

Series A in 2022
Bliq GmbH, established in 2019 and headquartered in Berlin, Germany, specializes in developing application software for gig workers in the transport industry. Its flagship product, Bliq Ride, enables registered drivers to automate their daily tasks by accepting or rejecting orders from multiple platforms simultaneously. The company's mission is to streamline work organization for rideshare and delivery drivers using traffic data, technology, and collective intelligence. As of now, Bliq employs 25 people.

Jomboy Media

Series A in 2022
Jomboy Media is an online media production company that specializes in creating and distributing original content centered around sports and pop culture. The company produces a variety of shows, including podcasts and digital series, catering to audiences who share a passion for topics such as sports, movies, songs, and history. By facilitating a platform for creators to develop their own content, Jomboy Media enhances the engagement of fans and enthusiasts in these areas. Through its diverse programming, the company aims to connect with audiences by delivering content that resonates with their interests and enthusiasm.

Wheelhouse

Series A in 2022
Wheelhouse, Inc. is a software company based in San Francisco, California, specializing in revenue management and pricing solutions for the short-term rental industry. Founded in 2014, Wheelhouse offers a data-driven platform that assists property owners in setting optimal rental prices by analyzing local home-sharing listings, hotel rates, and market trends. Its advanced pricing algorithm empowers users to maximize revenue and bookings by allowing them to customize rates based on factors such as seasonality and last-minute discounts. The company's mission is to enhance the capabilities of hosts and property owners, transforming them into more effective operators within the competitive rental market.

Nodar

Series A in 2022
Nodar, Inc. is a technology company based in Boston, Massachusetts, specializing in advanced sensor systems for various transportation modes, including cars, trucks, drones, ships, trains, and aircraft. Founded in 2018, Nodar develops innovative camera-based 3D vision systems, notably the Nodar Longbow and Hammerhead products. These systems utilize off-the-shelf cameras to provide long-range, high-precision depth sensing, making them suitable for Level 3 and Level 4 autonomous vehicle applications. Their technology is designed to enhance safety and performance in vehicles by enabling features such as collision warning, path planning, automatic emergency braking, and parking assistance. Nodar aims to deliver reliable and cost-effective sensor solutions that meet the evolving demands of the automotive, marine, and railway industries.

Evernow

Series A in 2022
Evernow is a provider of women's health care services focused on the unique needs of women before, during, and after menopause. The company offers an online teleconsultation platform that connects users with specialized doctors and provides access to science-backed information and treatments. This platform facilitates discussions and delivers resources on effective care for hormonal changes, empowering women to manage their health and enhance their quality of life during this significant life stage.

Antimatter

Series A in 2022
Antimatter is a company that provides cryptographic infrastructure services aimed at enhancing data security for B2B SaaS businesses. Founded in 2021 and located in Oakland, California, Antimatter's technology utilizes secure enclaves found in major cloud platforms to transparently encrypt customer data. This approach allows clients to adhere to stringent data security and privacy standards without necessitating any modifications to their existing code. By addressing the critical challenges of data security, Antimatter offers a solution that streamlines the protection of sensitive information for its customers.

Clockwork Systems

Series A in 2022
Clockwork Systems specializes in technology that enhances time-sensitive applications across on-premises data centers, public clouds, and hybrid environments. The company develops cloud management synchronization solutions that deliver ultra-accurate and scalable time services. By assessing network latency, Clockwork Systems optimizes application performance, enabling businesses to carry out critical functions like precise timestamping and the sequential execution of trades. This technology addresses fundamental latency issues, ultimately increasing productivity for enterprises that rely on accurate timing for their operations.

SafeBase

Series A in 2022
SafeBase, Inc. is a San Francisco-based company founded in 2020 that specializes in cloud-based security software aimed at helping organizations establish and enhance their security programs. The company’s offerings include a smart trust center platform that facilitates the sharing of security posture and automates access to sensitive documents. SafeBase provides solutions such as SafeBase Inspected, which features a website badge linking to a custom security status page, as well as custom security checklists and continuous monitoring of security systems. Additionally, the software assists organizations in configuring security policies, thereby enabling them to implement robust security practices effectively.

Weaviate

Series A in 2022
Weaviate is a technology company that specializes in developing a hybrid software-as-a-service (SaaS) platform for building advanced search and recommendation systems. The company offers an open-source AI vector search engine that includes various extensions tailored for specific applications, such as semantic search and plugins for easy integration into existing systems. Weaviate's platform is designed to efficiently scale applications from end-to-end, utilizing hybrid and multimodal search capabilities. It seamlessly integrates machine learning models within a purpose-built architecture that can accommodate billions of data objects, thus enabling clients to effectively leverage their machine learning applications.

Splice Bio

Series A in 2022
Splice Bio is a biotechnology company based in Barcelona, Spain, that specializes in developing innovative gene therapies using its proprietary intein platform technology. Founded in 2012, the company focuses on addressing the needs of patients suffering from incurable genetic diseases. Splice Bio's technology, originally developed in the Muir Lab at Princeton University, enhances the capabilities of traditional adeno-associated viruses (AAVs) by allowing for larger gene cargo delivery and targeting a broader range of tissues. This advancement aims to overcome existing limitations in gene therapy, making it a promising solution for treating complex genetic disorders. The company was formerly known as Proteodesign, S.L. before rebranding to Splice Bio in September 2020.

FTX US Derivatives

Series A in 2022
FTX US is a bitcoin options exchange designed to assist both individual traders and institutions in trading. FTX US allows users to trade a variety of digital assets like Bitcoin, Ethereum, Solana, and Dogecoin. The company was founded by Sam Bankman-Fried and Gary Wang in 2020 and is based in San Francisco, California.

Waymark

Series A in 2022
Waymark is a company focused on enhancing the accessibility and quality of healthcare for individuals who receive Medicaid. It offers community-based healthcare services aimed at improving patient outcomes. The company provides health plans, insulin education, training, and employment opportunities for community-based care teams. Additionally, Waymark partners with primary care providers to help Medicaid beneficiaries manage their health effectively.

Sorriso Pharmaceuticals

Series A in 2021
Sorriso Pharmaceuticals is a biotechnology company focused on developing disease-modifying antibodies aimed at treating inflammatory diseases such as Crohn's disease and ulcerative colitis. Founded in 2020 and headquartered in San Diego, California, Sorriso's innovative platform generates potent antibodies that can be administered orally, allowing for sustained activity throughout the intestinal system. This oral delivery method offers a significant advantage by alleviating the treatment burden associated with injectable antibody therapeutics, thus improving patient convenience and compliance. Through its research and development efforts, Sorriso Pharmaceuticals aims to provide effective solutions for individuals suffering from these challenging gastrointestinal conditions.

Belong Health

Series A in 2021
Belong Health is a health insurance company that focuses on providing Medicare Advantage and special needs plan products. It partners with local health plans to offer regionally informed and humanistic care to a growing community of individuals in need. By developing and enhancing market-leading health plans, Belong Health aims to deliver a straightforward Medicare experience for eligible members, ensuring they have access to quality healthcare through trusted insurance providers. The company's approach emphasizes collaboration with regional partners to address specific healthcare needs and improve the overall member experience.

Wonder

Series A in 2021
Wonder is a technology company that specializes in gaming and food delivery services. It offers an all-in-one gaming platform for Android mobile devices, enabling users to play, stream, and share games across various devices. Additionally, Wonder operates a food delivery service using trucks that function as mobile restaurants. Customers order food through a mobile app, and the Wonder trucks drive to a location near the user's home to prepare and deliver fresh meals on-site.

Tune Therapeutics

Series A in 2021
Tune Therapeutics is a biotechnology company focused on developing innovative cell and gene therapies. It employs an epigenetic programming platform to create novel therapeutic pathways, aiming to treat severe diseases without modifying the underlying DNA sequence.

AviadoBio

Series A in 2021
AviadoBio is a biotechnology company focused on developing transformative gene therapies for neurodegenerative disorders, specifically targeting diseases such as frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The company leverages innovative research from King’s College London and the UK Dementia Research Institute to create its therapeutic platform. By integrating a deep understanding of brain biology with proprietary gene therapies, AviadoBio aims to effectively address the challenges of delivering treatments to the appropriate areas within the nervous system. The ultimate goal is to enhance the therapeutic potential of gene therapy, potentially halting or even reversing the progression of these debilitating conditions, thereby improving the quality of life for affected individuals.

Prelay

Series A in 2021
Prelay is a developer of a team selling platform designed to enhance coordination and communication among revenue teams and internal stakeholders. The platform addresses common challenges in deal management by centralizing processes and team alignments, enabling users to streamline complex deal workflows and accelerate sales. By integrating with existing software tools, Prelay eliminates disjointed communication and tracking, allowing sales, presales, and revenue operations leaders to gain valuable insights into resource utilization and performance. This approach not only alleviates challenges faced by sales representatives but also fosters a more collaborative environment, ultimately driving revenue growth more efficiently.

Recludix Pharma

Series A in 2021
Recludix Pharma is a biotechnology company focused on drug discovery, specifically developing potent and selective inhibitors for challenging protein targets associated with cancer and autoimmune diseases. The company utilizes a unique platform that integrates custom-generated DNA-encoded libraries, massively parallel determination of structure-activity relationships, and proprietary screening tools. This innovative approach aims to enhance the identification and development of small molecule medicines, allowing medical professionals to create precision therapies tailored to specific protein targets. By addressing complex biological challenges, Recludix Pharma strives to advance treatment options in the healthcare sector.

Datafold

Series A in 2021
Datafold Inc. is a technology company that specializes in solutions for quality assurance and monitoring of analytical data. Founded in 2020 and headquartered in San Francisco, California, Datafold develops software that automates data quality management, helping organizations optimize their analytical data usage. Its offerings include tools for validating ETL code changes, monitoring data transfers, and enabling instant table comparison and profiling. By automating data engineering workflows, Datafold simplifies the data quality assurance process, allowing businesses to enhance the reliability and effectiveness of their analytical insights.

Merge

Series A in 2021
Merge is a technology company that provides a unified application programming interface (API) for seamless integration with various software platforms, including human resources, accounting, customer relationship management, and file storage. Founded in 2020 by Shensi Ding and Gil Feig, Merge simplifies the integrations lifecycle by facilitating the initial setup and offering tools for ongoing maintenance and observability. This platform allows businesses to efficiently manage their integrations, thereby enhancing sales processes, reducing customer churn, and accelerating the development of new products while minimizing engineering costs. With a presence in San Francisco, New York City, and Berlin, Merge has attracted significant investment to support its mission of transforming B2B customer-facing integrations.

Candy

Series A in 2021
Candy Digital is a rapidly growing company specializing in the creation and distribution of officially licensed non-fungible tokens (NFTs) and digital collectibles. Founded in 2021 by a group including Fanatics, Michael Rubin, Mike Novogratz, and Gary Vaynerchuk, Candy Digital aims to engage fans by providing authentic digital assets that connect them with their interests in sports, art, entertainment, and music. The company operates an NFT ecosystem platform that allows users to purchase, trade, and share these collectibles, ensuring a secure and scalable experience. Under the leadership of CEO Scott Lawin, Candy collaborates with athletes, artists, and content owners to produce unique digital offerings, enhancing the way fans interact with their passions through innovative digital assets.

Wizard

Series A in 2021
Wizard is a software development company based in New York, founded in 2021. It specializes in transforming e-commerce through the use of conversational AI. Wizard offers B2B solutions that enable brands to sell and market products directly through text messaging, enhancing customer engagement and increasing conversion rates beyond traditional e-commerce methods.

Slope.io

Series A in 2021
Slope.io, Inc. is a company that specializes in clinical trial logistics, catering to sponsors, contract research organizations (CROs), and research sites throughout the United States. Founded in 2016 and based in Mobile, Alabama, Slope.io offers a platform that streamlines the operational complexities associated with clinical trials. Its Slope.io Coordination service converts logistics requirements into organized schedules and workflows, while the Slope.io Kitting service provides customizable supply kits tailored to specific sites, patients, or study time points. The company emphasizes real-time coordination and complete traceability of devices, drugs, and kits from suppliers to research sites and patients.

Neural Magic

Series A in 2021
Neural Magic is a company that specializes in enterprise inference solutions aimed at enhancing the performance of open-source large language models across diverse infrastructures. By developing an inference engine software, Neural Magic accelerates artificial intelligence workloads on commodity hardware, allowing organizations to deploy AI models in a secure and cost-effective manner. Its technology leverages big data and deep learning to provide capabilities such as recommendations, image recognition, and object detection. This innovative approach enables businesses to overcome the limitations of traditional hardware accelerators, maximizing computational efficiency and hardware utilization.

858 Therapeutics

Series A in 2021
858 Therapeutics is a biotechnology company dedicated to the discovery of small molecule therapeutics aimed at treating cancers and other diseases, particularly those resistant to existing therapies. The company employs innovative strategies in areas such as synthetic lethality, innate immunity, and RNA modulation to develop its therapeutic candidates. Its lead program focuses on a PARG inhibitor, which is currently in early clinical development. By leveraging its platform to investigate the role of RNA modifying proteins in disease biology, 858 Therapeutics is generating a pipeline of targeted small molecules that address critical unmet medical needs in oncology and immunology.

Workera

Series A in 2021
Workera is a precision upskilling platform that enables enterprises, governments, and individuals to enhance their technological capabilities in areas such as data science, machine learning, and artificial intelligence. The platform utilizes AI-driven assessments and personalized learning plans to provide targeted mentorship and facilitate skill development. By offering an objective analysis of workforce skills, Workera helps organizations identify and mobilize talent effectively. Its approach includes measuring skills at a granular level, allowing for hyper-personalized learning experiences that drive measurable results. This capability equips organizations with actionable data, enabling them to make informed decisions regarding talent acquisition, mobility, coaching, and mentoring, ultimately addressing the critical skills gap in today's rapidly evolving technological landscape.

Vori Health

Series A in 2021
Vori Health is a healthcare organization that specializes in the treatment of musculoskeletal conditions through an innovative care delivery model. Established in 2020 and headquartered in New York, Vori Health provides a comprehensive range of services, including integrated medical and rehabilitation care, physical therapy, prescription management, imaging and lab ordering, health coaching, nutritional guidance, and community support. The company employs a virtual-first approach, connecting patients with a trained care team that includes board-certified, non-operative physical medicine physicians, health coach navigators, and physical therapists. This collaborative model ensures thorough initial assessments and coordinated care, aimed at guiding patients through their wellness journeys, particularly in addressing issues related to the back, neck, and joints.

Stablix

Series A in 2021
Stablix Therapeutics is a biotechnology company specializing in Targeted Protein Stabilization (TPS) to enhance disease treatment. The company has developed a platform that produces heterobifunctional small molecules, known as RESTORACS, which selectively recruit deubiquitinase enzymes. These enzymes remove ubiquitin from specific proteins, thereby stabilizing or increasing their levels and activity. Stablix is initially applying this innovative technology to create therapeutic programs aimed at addressing rare diseases, cancer, and immunological disorders, with the potential to improve patient outcomes in these challenging areas.

Vori Health

Series A in 2021
Vori Health is a healthcare organization that specializes in the treatment of musculoskeletal conditions through an innovative care delivery model. Established in 2020 and headquartered in New York, Vori Health provides a comprehensive range of services, including integrated medical and rehabilitation care, physical therapy, prescription management, imaging and lab ordering, health coaching, nutritional guidance, and community support. The company employs a virtual-first approach, connecting patients with a trained care team that includes board-certified, non-operative physical medicine physicians, health coach navigators, and physical therapists. This collaborative model ensures thorough initial assessments and coordinated care, aimed at guiding patients through their wellness journeys, particularly in addressing issues related to the back, neck, and joints.

Rapid Robotics

Series A in 2021
Rapid Robotics, Inc. is a San Francisco-based company that specializes in manufacturing automated cell robots for the manufacturing and logistics sectors. Founded in 2019, the company addresses the challenges posed by labor shortages and the increasing complexity of material handling by providing adaptable robotic palletizing solutions. Its technology enables the rapid deployment of robotic arms for various tasks, allowing manufacturers to implement automation within hours rather than weeks, and at a lower cost compared to traditional solutions that require extensive programming. Rapid Robotics utilizes an AI-driven, vision-based platform to accommodate a wide range of palletizing applications. By offering a Robotics as a Service (RaaS) business model, the company enhances operational capacity and predictability while minimizing the risks associated with robot ownership and maintenance, ultimately driving increased production efficiency and margin improvement for its clients.

Goody

Series A in 2021
Goody is a corporate gifting platform that simplifies the process of sending gifts, making it as effortless as sending a text message. The company offers a curated selection of gifts, including robes, cookies, succulents, and spa treatments, which can be chosen without needing the recipient's size information. Recipients have the flexibility to select their preferred size or type of gift or exchange it for another option of similar value. Goody's payment system is designed to enhance user experience, as payments are only processed once the gift is received, ensuring a more personal and considerate gifting experience for both businesses and individuals.

Theorycraft Games

Series A in 2021
Theorycraft Games operates as an independent game development studio that operates remotely. The company is in process of developing its first game codenamed Loki. Theorycraft was founded in 2020 and is headquartered in Los Angeles, California, United States.

Rocket.Chat

Series A in 2021
Rocket.Chat Holdings, Ltd., established in 2015, specializes in developing and operating an open-source web chat platform. The company offers a comprehensive suite of features, including video conferencing, helpdesk chat, file sharing, and screen sharing, along with API and native mobile applications. Rocket.Chat also provides white labeling, integrations, and hosting services. With over 500,000 servers installed and 12 million users worldwide, the platform facilitates internal and external communication within a secure environment. Users can run Rocket.Chat on-premises or on the cloud, tailoring the platform with features like individual and group communication, video conferencing, and integration with various external communications platforms. The company's long-term vision is to replace email with a real-time, federated communications platform and foster a marketplace for app-building and services.

Narmi

Series A in 2021
Narmi Inc. is a technology company that specializes in developing online and mobile banking applications for financial institutions across the United States. Founded in 2016 and headquartered in New York, Narmi provides a comprehensive platform that allows regional and community banks and credit unions to attract, engage, and retain customers effectively. The company’s applications facilitate account openings in under 2.5 minutes, while ensuring a secure and user-friendly experience through features such as fraud protection, multi-factor authentication, and transaction monitoring. In addition to banking applications, Narmi also offers services in website design, development, hosting, and content management, helping financial institutions create a dynamic and engaging digital presence.

New Wave Foods

Series A in 2021
New Wave Foods, Inc., established in 2015 and headquartered in San Francisco, specializes in producing and selling plant-based seafood products. The company offers a range of shrimp alternatives, including sautéed, grilled, breaded, and fried options, as well as shrimp tacos and salads. These products are made from sustainably sourced seaweed, soy protein, and natural flavors, providing a sustainable and healthier alternative to traditional seafood. New Wave Foods serves customers in the culinary market across the United States, positioning itself as a leader in sustainable seafood.

Polyneuron Pharmaceuticals

Series A in 2020
Polyneuron Pharmaceuticals AG is a biopharmaceutical company based in Basel, Switzerland, focused on developing innovative therapeutics for the treatment of autoimmune disorders. Founded in 2014, the company specializes in creating drugs to target specific autoimmune conditions, including PN-1007 for anti-MAG neuropathy, PN-1018 for multifocal motor neuropathy, and PN-032 and PN-056 for ABO-incompatible transplantation. Polyneuron's therapeutic approach employs biodegradable glycopolymers that selectively eliminate pathological autoantibodies, preserving the overall integrity of the immune system. This technology, referred to as Antibody-Catch, aims to provide safe and effective treatment options for patients suffering from autoimmune diseases affecting the peripheral nervous system, particularly those involving autoantibodies against carbohydrate epitopes.

Korro Bio

Series A in 2020
Korro Bio Inc., established in 2018 and headquartered in Cambridge, Massachusetts, specializes in developing nucleic acid-based therapeutics targeting specific sequences in genetic code to treat rare diseases. The company's proprietary platform enables efficient and selective RNA editing, leveraging natural processes common to all multicellular organisms. Korro Bio aims to advance this technology to effect changes in protein structure and function across multiple tissues, expanding the reach of genetic medicines with additional precision and tunability by editing RNA instead of DNA.

GRID

Series A in 2020
GRID is a productivity tool that transforms everyday Excel spreadsheets into modern web applications, allowing users to create interactive web documents without requiring new skills. This platform offers an editor that automates the conversion process, enabling users to generate visually appealing and interactive web reports from their spreadsheets. Additionally, GRID facilitates secure sharing and analysis of these documents, empowering clients to turn traditional spreadsheets into dynamic dashboards or applications that enhance collaboration and usability.

MBX Biosciences

Series A in 2020
MBX Biosciences, Inc. is a biotechnology company founded in 2018 and based in Carmel, Indiana. The company specializes in developing therapeutics for rare endocrine disorders, focusing on conditions that currently lack effective treatments. MBX Biosciences aims to discover, develop, and commercialize first-in-class therapies, particularly peptides designed to address endocrine genetic diseases that affect glandular hormone production and the body’s chemical messaging systems.

Monte Rosa Therapeutics

Series A in 2020
Monte Rosa Therapeutics is a biotechnology company dedicated to developing innovative cancer therapeutics through the modulation of protein degradation pathways. Specializing in molecular glue degraders (MGDs), the company utilizes the body's natural mechanisms for protein destruction to selectively degrade proteins that are relevant to therapeutic outcomes. Employing its QuEEN platform, which integrates artificial intelligence and proprietary experimental tools, Monte Rosa identifies target proteins for degradation by MGDs from its extensive library of over 50,000 molecules. The company's most advanced product candidate, MRT-2359, specifically targets the translation termination factor protein GSPT1, showing promise for the treatment of MYC-driven tumors. Monte Rosa Therapeutics aims to deliver pioneering therapies for cancer and potentially other diseases through its innovative approaches.

Beyond Identity

Series A in 2020
Beyond Identity, Inc. is a New York-based company that specializes in cloud-native passwordless identity management solutions. Founded in 2019, it aims to enhance digital security by replacing traditional passwords with secure, X.509-based certificates. This innovative approach creates a robust Chain of Trust, incorporating user and device identity along with a real-time assessment of device security for adaptive authentication and authorization. Beyond Identity's platform facilitates frictionless login experiences through biometric authentication and seamless integration with Single Sign-On (SSO) systems, catering to employees, contractors, and customers alike. By eliminating the use of passwords, the company helps organizations mitigate risks associated with credential-stuffing attacks and streamline their authentication processes, ultimately enabling greater business agility and cost efficiency.

Vimaan

Series A in 2020
Vimaan is a company specializing in computer vision and AI solutions designed to enhance inventory management in warehouses. Their technology automates and digitizes various inventory tasks, including receiving goods, storing items, picking orders, stock counting, order verification, and shipping. Vimaan's products, such as DockTrack, StorTrack, and PickTrack, are utilized across industries like warehousing, construction management, security, factory automation, and facility maintenance. The company aims to address the persistent challenge of maintaining accurate inventory records in warehouse environments, thereby helping clients optimize their supply chain operations.

Affinia Therapeutics

Series A in 2020
Affinia Therapeutics Inc. is a biotechnology company focused on developing gene therapies for the treatment of severe diseases affecting the muscle and central nervous system (CNS). Established in 2019 and based in Waltham, Massachusetts, the company specializes in creating adeno-associated virus (AAV) vectors and utilizes a platform that integrates synthetic and systems biology with high-throughput screening techniques. This innovative approach allows Affinia Therapeutics to design novel gene therapies with enhanced properties tailored to address significant unmet medical needs. The company aims to provide healthcare professionals with advanced therapeutic options for patients suffering from debilitating conditions.

ClearMetal

Series A in 2020
ClearMetal, Inc. is a San Francisco-based company that specializes in artificial intelligence software for supply chain operations. Founded in 2014, it provides transport and supply chain visibility solutions through its cloud-based platform. The company leverages proprietary machine learning algorithms to enhance the accuracy and quality of freight data, enabling organizations to obtain real-time insights into shipment status, estimated arrival times, and potential delays. This advanced analytics capability allows shippers to manage exceptions efficiently and improve overall customer experience. ClearMetal's focus on delivering continuous visibility helps supply chain organizations optimize logistics and maintain easy access to reliable information about their shipments.

Dandelion Energy

Series A in 2020
Dandelion Energy, Inc. is a Palo Alto, California-based company founded in 2017 that specializes in affordable geothermal heating and cooling solutions. The company replaces traditional air conditioning and heating systems with an innovative home geothermal system that utilizes a powerful heat pump and underground pipes to transfer heat between the earth and the residence. This system is designed to harness thermal energy from below the earth's surface to regulate indoor temperatures and provide hot water, allowing homeowners to transition from conventional heating fuels to a more sustainable geothermal alternative. Dandelion Energy is committed to making renewable heating and cooling accessible and cost-effective for homeowners.

Lily AI

Series A in 2020
Lily AI is an innovative e-commerce product discovery platform based in Mountain View, California, that focuses on enhancing the sales performance of brands and retailers. The company specializes in integrating customer-centric product attributes into various facets of the e-commerce ecosystem, including site search engines and recommendation systems. By aligning brand messaging with customer intent, Lily AI improves on-site search, personalized product discovery, and demand prediction. This approach enables retailers, particularly in the fashion, home, and beauty sectors, to achieve significant increases in traffic, conversion rates, revenue, and brand loyalty.

Anyscale

Series A in 2019
Anyscale, Inc. is a technology company that focuses on simplifying distributed AI development through its innovative programming platforms and tools. Founded in 2019 by the creators of Ray, Anyscale has developed the Ray framework, which is an open-source project that allows software developers and machine learning engineers to effortlessly scale their applications from a personal laptop to cloud environments. The company's solutions enable developers of varying skill levels to manage the complete AI lifecycle on a unified computing substrate, facilitating the rapid development and deployment of AI products. Based in Berkeley, California, Anyscale aims to accelerate the productionization of AI applications, making it easier and more cost-effective for organizations to bring AI solutions to market.

Shape Therapeutics

Series A in 2019
Shape Therapeutics, Inc. is a biotechnology company focused on RNA-editing gene therapy for various medical conditions, including neurodegenerative disorders, oncology, metabolic diseases, and rare genetic disorders. Founded in 2018 and headquartered in Seattle, Washington, the company utilizes its proprietary RNAfix technology to edit RNA using the body’s natural cellular machinery. This approach minimizes risks associated with immunogenicity, cellular toxicity, and unintended DNA editing. Shape Therapeutics is dedicated to advancing its innovative platforms for payload, delivery, and manufacturing to enable the development of effective treatments, aiming to address critical health challenges and improve patient outcomes.

The Yes

Series A in 2019
The Yes is an artificial intelligence-based shopping platform founded in 2018 and headquartered in Burlingame, California, with additional operations in New York City. The company aims to transform the e-commerce landscape by leveraging AI technology to enhance the online shopping experience. By focusing on innovative solutions, The Yes seeks to attract critical thinkers who can contribute to reimagining the rules of online retail. The platform is dedicated to creating a dynamic and engaging shopping environment for users.

Aquabyte

Series A in 2019
Aquabyte, Inc. is a technology company that specializes in developing innovative monitoring systems for the aquaculture industry. Founded in 2017 and based in San Francisco, California, with an additional office in Bergen, Norway, Aquabyte leverages computer vision and machine learning to enhance fish farming practices. Its smart camera system enables functionalities such as real-time sea lice counting, biomass estimation, appetite detection, and feed optimization. By providing a web dashboard for continuous monitoring, Aquabyte aims to improve the efficiency, sustainability, and profitability of fish farms. The company's solutions are designed to reduce operational costs and minimize fish mortality while also addressing the environmental impact of aquaculture. With a diverse team of experts in machine learning, entrepreneurship, and aquaculture biology, Aquabyte is committed to delivering practical and effective solutions for the industry.

Block Renovation

Series A in 2019
Block Renovation is a home renovation platform that aims to simplify the complex process of planning, designing, and executing home improvements. Founded by Koda Wang and Luke Sherwin, the company integrates architect-grade design, construction labor, and materials into a cohesive experience. By bringing design, sourcing, and project management under one roof, Block Renovation provides homeowners with clarity regarding outcomes, quality, pricing, and timelines. This streamlined approach not only enhances the renovation experience for homeowners but also offers contractors a more efficient way to operate. Ultimately, Block Renovation seeks to improve living spaces while elevating the standards of the renovation industry.

Level

Series A in 2019
Level, operating under the name Zero Financial, Inc., is a financial technology company based in San Francisco, California, that offers a modern mobile banking experience. The company's primary products include a mobile banking application, a debit card known as Zerocard, and a checking account called Zero Checking. The app provides users with real-time insights into their finances, displaying debit card purchases alongside other transactions to help manage their budgets effectively. Unlike traditional banking options, Zerocard combines the convenience of a debit card with the benefits of a credit card, offering users unlimited cash back rewards ranging from 1.0% to 3.0% on expenditures, as well as competitive annual interest rates on account balances. Level aims to eliminate common banking fees, striving to simplify personal finance management for its users.

Reneo Pharmaceuticals

Series A in 2019
Reneo Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company based in San Diego, California, dedicated to developing therapies for patients with rare genetic mitochondrial diseases. These conditions are characterized by deficits in cellular metabolism and energy production, often leading to significant health challenges. The company is focused on creating treatments that improve mitochondrial function, preserve muscle integrity, and enhance the overall quality of life for affected individuals. Its lead product candidate, REN001, is an oral medication designed to modulate genes critical to the production of adenosine triphosphate (ATP), the primary energy source for cellular processes. Founded in 2014, Reneo aims to address the unmet needs of patients suffering from orphan metabolic diseases linked to mitochondrial dysfunction.

ARRIS

Series A in 2019
ARRIS specializes in advanced manufacturing technologies, particularly in the development of performance composites for various mass-market applications, including aerospace, automotive, and consumer products. The company's innovative additive molding technology enables the production of 3D-aligned continuous fiber thermoplastic composite parts at scale. This proprietary process allows for the precise alignment of continuous carbon fibers and the integration of electronic components and multifunctional materials into a single, topology-optimized structure. By combining these elements, ARRIS provides clients with access to advanced composite solutions that enhance product performance and efficiency.

Spyglass Ophthalmics

Series A in 2019
Spyglass Ophthalmics, Inc. is a company based in Mission Viejo, California, specializing in the development of ophthalmic therapeutic devices. Founded in 2019, Spyglass focuses on creating innovative solutions to enhance vision and eye care for patients. The company's products target unmet needs in areas such as cataract treatment, lens replacement, and other chronic ophthalmic diseases. By providing these devices, Spyglass aims to ensure that patients receive quality eye treatment at an affordable cost.

AppSheet

Series A in 2019
AppSheet is an intelligent no-code platform established in 2014 and headquartered in Seattle, Washington. It enables business users to create powerful, code-free applications by leveraging their business data. The platform connects with various data sources, including cloud storage services and relational databases, allowing for quick generation of customizable applications. These applications can incorporate advanced features such as offline access, workflow rules, and machine learning capabilities, and they are designed to run seamlessly on web, iOS, Android, and messaging platforms. AppSheet's focus on simplifying app development helps organizations meet IT governance and security requirements while enhancing the end-user experience through rich, custom software solutions.

Metabase

Series A in 2019
Metabase is an open-source analytics and business intelligence application founded in 2014 and headquartered in San Francisco, California. The platform enables users to create dashboards and automated reports, facilitating the measurement, analysis, and sharing of data. It is designed to help businesses navigate complex data environments by providing tools to observe trends over time. Additionally, Metabase offers professional services such as managed hosting and support, assisting organizations in implementing customized analytics and business intelligence solutions.

The Well

Series A in 2019
The Well is a New York-based wellness club and spa offering membership-based access to integrative healthcare services. It combines Western medicine with Eastern healing practices, providing personalized care plans tailored to individual members' needs. The company's team of doctors, practitioners, and health coaches collaborate under one roof to deliver science-backed wellness experiences and products, empowering urban professionals to take charge of their health.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.